Haohai Biotech: Announcement of Shanghai Haohai Biotechnology Co., Ltd. on the progress of the second phase of the repurchase of the company\'s A-share shares through centralized bidding
Haohai Biotech: Announcement of Shanghai Haohai Biotechnology Co., Ltd. on canceling the repurchased H shares
Working Rules of the Strategy and Sustainable Development Committee of the Board of Directors of Shanghai Haohai Biotechnology Co., Ltd. (Revised in October 2024)
Working Rules of the Audit Committee of the Board of Directors of Shanghai Haohai Biotechnology Co., Ltd. (Revised in October 2024)
Haohai Biotech: Announcement of Shanghai Haohai Biotechnology Co., Ltd. on adjusting the maximum price limit for the repurchase of A-shares after the implementation of equity distribution for the 2024 semi-year
Articles of Association of Shanghai Haohai Biotechnology Co., Ltd. (revised in September 2024)
Legal Opinions of Shanghai AllBright Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Haohai Biotechnology Co., Ltd., the 2024 Second Class A Shareholders\' Meeting, and the 2024 Second Class H Shareholders\' Meeting
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Haohai Biotechnology Co., Ltd., the 2024 Second Class A Share Shareholders\' Meeting, and the 2024 Second Class H Shareholders\' Meeting
Meeting materials for the first extraordinary general meeting of shareholders in 2024, the second A-share category general meeting of shareholders in 2024, and the second H-share category general meeting of shareholders in 2024.
Notice of the 2024 First Extraordinary General Meeting of Shareholders, the 2024 Second A-Share Category Shareholders' Meeting, and the 2024 Second H-Share Category Shareholders' Meeting of Shanghai Haohai Biotechnology Co., Ltd.
Announcement of the share buyback of A-shares by Shanghai Haohai Biotech Co., Ltd. and the shareholding status of the top ten shareholders and the top ten non-restricted shareholders.
Announcement Regarding Change of Registered Capital and Revision of Company Articles of Association of Shanghai Haohai Biotec Co., Ltd.
Special System for Preventing Major Shareholders and Related Parties of Shanghai Haohai Biotechnology Co., Ltd. from Occupying Company Funds.
Articles of Association of Shanghai Haohai Biotechnology Co., Ltd. (Revised in August 2024)
Announcement of Shanghai Haohai Biotech Co., Ltd. Regarding the Change of Registered Capital, Revision of the Company's Articles of Association and Some Governance Systems.
Shanghai Haohai Biotechnology Co., Ltd. announcement on the voluntary disclosure of its wholly-owned subsidiary's cross-linked sodium hyaluronate gel for injection product obtaining the medical device registration certificate.
Disclosure of the financial report on the following day.
Disclosure of the financial report on the following day.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shanghai Haohai Biotechnology Co., Ltd., the 2024 First Class A Shareholders' Meeting, and the 2024 First Class H Shareholders' Meeting
Legal Opinions of Shanghai AllBright Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Haohai Biotechnology Co., Ltd., the first Class A Shareholders' Meeting in 2024, and the 1st Class H Shareholders' Meeting in 2024
No Data
No Data